Hints and tips:
...Michael Leuchten, an analyst at UBS, said that even during the pandemic, many experts had predicted that the vaccines would not present a secure annual revenue scheme....
...Personally, I hold Michael Douglas wearing a chunky bottle green jumper over a bare chest in 1992’s Basic Instinct as the pinnacle of V-neck wearing....
...“As the IPO market begins to open, we look forward to welcoming a robust pipeline of companies,” said Michael Harris, NYSE’s global head of capital markets....
...Justice, intend to follow through on their mission to draw a tougher line on antitrust.Still outstanding are large contested deals, including Amgen’s planned $28bn takeover of Horizon Therapeutics and Pfizer...
...The oncology-focused biotech agreed a $43bn deal to be acquired by Pfizer....
...Additional help by Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley....
...But Michael Mina, a former Harvard professor who is now chief medical officer at testing company eMed, suspects it could happen in 20 to 30 per cent of patients....
...BioNTech referred the FT to the Pfizer statement and declined to comment further....
...Read the full story, from the FT’s Bryan Harris and Michael Stott in Brazil, here....
...Tishman Speyer, one of New York’s largest commercial property developers, had previously secured pharmaceuticals company Pfizer as its anchor tenant for the Spiral....
...to get boosted,” said Michael Yee, analyst at Jefferies....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...“I see this as a personal choice and equity question and not a mandate for all,” said Michael Nelson, professor of medicine at the University of Virginia....
...Michael Mina, assistant professor of epidemiology at Harvard, says vulnerable people should be given home Covid tests, which could be authenticated remotely and enable prescriptions to be delivered by an...
...Individuals Most innovative Law firm leader Ira Coleman, McDermott, Will & Emery Most Innovative legal practitioner Arif Ali, Dechert Most Innovative Law firm change maker Michael Hertz, White & Case...
...Pfizer’s pill blocks an enzyme that coronavirus needs to replicate....
...the trading day were intense, with gauges of volatility surging to the highest levels since since October 2020, ahead of the US election and results of the effectiveness of vaccines being developed by Pfizer...
...It expects initial results from the trial in the fourth quarter.Additional reporting by Michael Peel in Brussels...
...“It really is ethically concerning,” said Michael Carome, director of the health research group at advocacy group Public Citizen....
...Pfizer declined to comment on the price of the shot....
...EU officials have spent the past week at loggerheads over how to distribute a portion of the 10m Pfizer jab deliveries brought forward from the third quarter....
...The EMA is conducting a rolling review of Sputnik V but has yet to authorise it for use across the bloc....
...A UK government spokesperson said: “We are in the process of understanding the implications of Pfizer’s announcement today to our plans....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Hungary has ordered doses of the BioNTech/Pfizer, Moderna and Oxford/AstraZeneca vaccines via the EU but is the only member of the bloc to have also approved the Sinopharm and Russia-made Sputnik V vaccines...
International Edition